Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CORRECTION: Dynavax Technologies Q1 Adj. EPS $(0.11) Misses $0.04 Estimate, Sales $68.16M Miss $70.58M Estimate

Author: Benzinga Newsdesk | May 06, 2025 06:49pm
Dynavax Technologies (NASDAQ:DVAX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $0.04 by 375 percent. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $68.16 million which missed the analyst consensus estimate of $70.58 million by 3.43 percent. This is a 34.21 percent increase over sales of $50.79 million the same period last year.

Posted In: DVAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist